Name Net increased
positions
Increased positions Reduced positions Return since
30 Sep ‘13
51
10 22 12 59.6%
52
10 12 2 92.4%
53
10 14 4 168%
PLX icon
54
Protalix BioTherapeutics
PLX
$164M
10 21 11 95.5%
55
10 55 45 56.7%
56
10 32 22 86.3%
57
9 17 8 34.9%
58
9 40 31 90.2%
59
9 11 2 99.1%
60
9 23 14 63.3%
XPH icon
61
State Street SPDR S&P Pharmaceuticals ETF
XPH
$235M
9 23 14 47.3%
62
9 17 8 89.1%
63
9 45 36 88.9%
64
9 14 5 21.1%
65
9 48 39 46.5%
66
9 45 36 84.2%
67
9 16 7 46.4%
68
8 8 0 0.7%
69
8 13 5 1.26%
70
8 14 6 26.5%
71
8 35 27 87.5%
72
8 29 21 90.4%
73
8 41 33 83.4%
74
8 11 3 100%
75
8 31 23 93.9%